| 11964989 |
KRas G12D inhibitors |
Xiaolun Wang, Aaron Craig Burns, James Gail Christensen, John Michael Ketcham, John David Lawson +21 more |
2024-04-23 |
|
| 11453683 |
KRas G12D inhibitors |
Xiaolun Wang, Aaron Craig Burns, James Gail Christensen, John Michael Ketcham, John David Lawson +21 more |
2022-09-27 |
|
| 11247990 |
Bicyclic fused pyridine compounds as inhibitors of TAM kinases |
Shelley Allen, Mark Laurence Boys, Adam Cook, John Gaudino, Ronald Jay Hinklin +4 more |
2022-02-15 |
|
| 10669269 |
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors |
Mark Laurence Boys, Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, David A. Mareska +7 more |
2020-06-02 |
|
| 10647715 |
KRas G12C inhibitors |
Matthew Arnold Marx, Thomas P. Bobinski, Aaron Craig Burns, John Gaudino, Julia Haas +5 more |
2020-05-12 |
|
| 10154995 |
Serine/threonine kinase inhibitors |
James F. Blake, Adam Cook, Indrani W. Gunawardana, Kevin W. Hunt, Michael Lyon +10 more |
2018-12-18 |
$38,366,000 |
| 9969694 |
N-(arylalkyl)-N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors |
James F. Blake, Barbara J. Brandhuber, Julia Haas, Allen A. Thomas, Shannon L. Winski |
2018-05-15 |
$20,875,000 |
| 9809590 |
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors |
Mark Laurence Boys, Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, David A. Mareska +7 more |
2017-11-07 |
$14,586,000 |
| 9763942 |
Serine/threonine kinase inhibitors |
James F. Blake, Adam Cook, Indrani W. Gunawardana, Kevin W. Hunt, Michael Lyon +10 more |
2017-09-19 |
|
| 9670208 |
Serine/threonine kinase inhibitors |
James F. Blake, Adam Cook, John Gaudino, Indrani W. Gunawardana, Erik James Hicken +11 more |
2017-06-06 |
$33,372,000 |
| 9655904 |
Substituted benzoazepines as toll-like receptor modulators |
James Jeffry Howbert, Gregory Dietsch, Robert Hershberg, Laurence E. Burgess, Joseph P. Lyssikatos +1 more |
2017-05-23 |
$35,230,000 |
| 9174981 |
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors |
Mark Laurence Boys, Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, David A. Mareska +7 more |
2015-11-03 |
$10,851,000 |
| 9126940 |
Substituted benzoazepines as toll-like receptor modulators |
James Jeffry Howbert, Gregory Dietsch, Robert Hershberg, Laurence E. Burgess, Joseph P. Lyssikatos +1 more |
2015-09-08 |
$6,159,000 |
| 8691809 |
Substituted benzoazepines as toll-like receptor modulators |
James Jeffry Howbert, Gregory Dietsch, Robert Hershberg, Laurence E. Burgess, Joseph P. Lyssikatos +1 more |
2014-04-08 |
$6,320,000 |
| 8394795 |
Pyrazole [3, 4-B] pyridine Raf inhibitors |
Kateri A. Ahrendt, Alexandre Joseph Buckmelter, Jason De Meese, Jonas Grina, Joshua Hansen +14 more |
2013-03-12 |
$6,100,000 |
| 8338452 |
Raf inhibitor compounds and methods of use thereof |
Kateri A. Ahrendt, Alexandre Joseph Buckmelter, Jonas Grina, Joshua Hansen, Ellen Laird +10 more |
2012-12-25 |
|
| 7566716 |
Imidazopyrazines as Raf inhibitor compounds |
Ellen Laird, George T. Topalov, Joseph P. Lyssikatos, Mike Welch, Jonas Grina +1 more |
2009-07-28 |
$3,368,000 |
| 7491829 |
RAF inhibitor compounds and methods |
Ellen Laird, Joseph P. Lyssikatos, Mike Welch, Jonas Grina, Josh Hansen +2 more |
2009-02-17 |
|
